Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
Jean‐Pierre Gérard(Centre Antoine Lacassagne), Laurent Bedenne(CHU Dijon Bourgogne), Marie-Thérèse Closon-Dejardin(Université Claude Bernard Lyon 1), Thierry Conroy(Inserm), Bernard Leduc(Université Claude Bernard Lyon 1), Éric François(Centre Antoine Lacassagne), Franck Bonnetain(Azienda Ospedaliera Universitaria Pisana), O. Chapet(Université Claude Bernard Lyon 1), M. Untereiner(Université Claude Bernard Lyon 1), Olivier Bouché(CHU Dijon Bourgogne), R Mackiewicz(Université Claude Bernard Lyon 1), Michel Ducreux(Université Paris-Saclay), Bruno Buecher(Université Paris Sciences et Lettres), Jean‐François Seitz(Aix-Marseille Université), J Maurel(Université Claude Bernard Lyon 1)
Cited by 1,735
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
|Journal of Clinical Oncology|2011|2.1k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
|The Lancet Oncology|2021|1.3k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k